Overview
Edison’s healthcare-focused trusts report examines the current state and prospects of healthcare-focused investment trusts, highlighting the sector’s resilience and potential for recovery following the COVID-19 pandemic and subsequent market corrections.
Key overall themes
- Sector performance: the healthcare sector, particularly small- and mid-cap biotech companies, is poised for a turnaround due to attractive valuations and a return to fundamentals.
- Investment opportunities: our report identifies key investment opportunities within the sector, driven by innovation, patent cliffs in big pharma and potential M&A activities.
- Role of investment companies: investment companies offer investors a strategic way to gain exposure to the healthcare sector, while managing risks, through diversified portfolios and professional management expertise.
Core insights
- COVID-19 impact: investor sentiment and government stimulus during the pandemic drove the sector to historical highs, but subsequent monetary tightening led to a capital flight from biotech, causing a market correction.
- Current market conditions: with interest rates stabilising and beginnings of a reversal in the cycle, the sector is receiving renewed attention, particularly in innovative biotech stocks and companies with strong fundamentals.
- Investment companies: the report profiles several healthcare-focused investment companies, detailing their strategies, portfolio compositions and performance metrics.
- Major sector drivers: biotech companies are expected to lead the charge, supported by innovation and a growing appetite for M&A in big pharma and broader megatrends.
Selected investment companies
Our report provides profiles of various investment trusts, including:
- BB Biotech (BION)
- BioPharma Credit (BPCR)
- Bellevue Healthcare Trust (BBH)
- Biotech Growth Trust (BIOG)
- HBM Healthcare Investments (HBMN)
- International Biotechnology Trust (IBT)
- IP Group (IPO)
- Polar Capital Global Healthcare Trust (PCGH)
- RTW Biotech Opportunities (RTW)
- Syncona (SYNC)
- Worldwide Healthcare Trust (WWH)
- Xlife Sciences (XLS)
Conclusion
We conclude that the healthcare sector, particularly biotechnology, is on the mend and offers significant investment opportunities. Investment trusts are positioned as a viable means for investors to navigate the complexities of the sector and capitalise on its potential upside.
Register for free below to read the full report.
